Royalty Pharma scores $2.2B IPO — the biggest of the year

Royalty Pharma scores $2.2B IPO — the biggest of the year

Source: 
Endpoints
snippet: 

A pharma IPO has snatched the crown for the largest US listing of the year.

Royalty Pharma raised $2.2 billion — the exact amount outlined in the latest filing — by pricing at $28 per share, the top of the range. On its first day on the Nasdaq, it’s valued at $16.67 billion.